Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8071 to 8085 of 8216 results

  1. Mirikizumab for treating moderately to severely active Crohn's disease [ID6244]

    In development [GID-TA11267] Expected publication date: 13 November 2024

    Technology appraisal guidance
    In development

  2. RespiraSense (MT736)

      Status ...

    Medical technologies guidance
    Topic selection

  3. Cyanoacrylate glue for hernia mesh fixation (MT707)

      Status ...

    Medical technologies guidance
    Topic selection

  4. Andexanet alfa for reversing anticoagulation in people with intracranial haemorrhage (part review of TA697) [ID6335]

    Awaiting development [GID-TA11472] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  5. The Insides System chyme reinfusion system (MT682)

      Status ...

    Medical technologies guidance
    Topic selection

  6. d-NAV for optimization of personal insulin management in adults with type 2 diabetes (MT696)

      Status ...

    Medical technologies guidance
    Topic selection

  7. TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512)

      Status ...

    Medical technologies guidance
    Topic selection

  8. Lumella Pre-Eclampsia point-of-care test for assessing pre-eclampsia risk (MT687)

      Status ...

    Diagnostics guidance
    Topic selection

  9. Pitolisant for treating narcolepsy in children and young people 6 to 17 years ID6353

    In development [GID-TA11394] Expected publication date: TBC

    Technology appraisal guidance
    In development

  10. Danicopan as an add-on treatment to a C5 inhibitor for treating extravascular haemolysis in adults with paroxysmal nocturnal haemoglobinuria [ID5088]: draft guidance

    We are listening to your views on this Technology appraisal guidance. Comments close 19 June 2024.

    Technology appraisal guidance
    In consultation

  11. O2Matic pro 100 (MT746)

      Status ...

    Medical technologies guidance
    Topic selection

  12. Signatera molecular residual disease assay (MT741)

      Status ...

    Medical technologies guidance
    Topic selection

  13. Stockholm3 blood test for prostate cancer, (MT734),

      Status ...

    Diagnostics guidance
    Topic selection

  14. PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetes, (MT740)

      Status ...

    Diagnostics guidance
    Topic selection

  15. Ambu aScope 4 Broncho for routine diagnostic and therapeutic bronchoscopy, (MT158)

      Status ...

    Diagnostics guidance
    Topic selection